Prime Study Finds Lower Adherence, Higher Costs for Weight Loss Drugs | AMCP 2024

Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime Therapeutics/MagellanRx Management poster at AMCP 2024

April 16, 2024

Related news

In the news

May 8, 2024

Meet the Board: Navigating the Evolving Landscape of Healthcare Coverage and Pharmacy Benefits with Marci Chodroff of Magellan, Prime Therapeutics

Managed Healthcare Executive: This month's episode of the Meet the Board podcast features a new member of our editorial advisory board, Marci J. Chodroff, MD, FACP, vice president of Medical Affairs at Magellan Rx Management, a Prime Therapeutics company

In the news

April 24, 2024

AMCP 2024: Key Takeaways From Leading Speakers

American Journal of Managed Care (AJMC): Session speakers at the Academy of Managed Care Pharmacy (AMCP) 2024 annual conference share their favorite parts of the event and the key takeaways they will leave the conference with